FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William Hewlett

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Co-author Network

Publications

TOP 3
Chong-Bin Zhu; Nicholas G Campbell; William A Hewlett; Kathryn M Lindler; James S Sutcliffe; Randy D Blakely
Colocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors.
Chong-Bin Zhu; Kathryn M Lindler; Anthony W Owens; Lynette Daws; Randy D Blakely; William A Hewlett
Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters.
Chong-Bin Zhu; Jennifer A Steiner; Jaclyn L Munn; Lynette Daws; William A Hewlett; Randy D Blakely
Rapid stimulation of presynaptic serotonin transport by A(3) adenosine receptors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William Hewlett (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Chong-Bin Zhu; Nicholas G Campbell; William A Hewlett; Kathryn M Lindler; James S Sutcliffe; Randy D Blakely
Colocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors.
Molecular pharmacology 2011;80(3):458-65.
2010: Chong-Bin Zhu; Kathryn M Lindler; Anthony W Owens; Lynette Daws; Randy D Blakely; William A Hewlett
Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(13):2510-20.
2007: Chong-Bin Zhu; Jennifer A Steiner; Jaclyn L Munn; Lynette Daws; William A Hewlett; Randy D Blakely
Rapid stimulation of presynaptic serotonin transport by A(3) adenosine receptors.
The Journal of pharmacology and experimental therapeutics 2007;322(1):332-40.
2006: Chong-Bin Zhu; Randy D Blakely; William A Hewlett
The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(10):2121-31.
2006: alexandre bonnin; W Peng; William A Hewlett; Pat Levitt
Expression mapping of 5-HT1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain development.
Neuroscience 2006;141(2):781-94.
2005: Harish C Prasad; Chong-Bin Zhu; Jacob McCauley; Devadoss J Samuvel; Sammanda Ramamoorthy; Richard C Shelton; William A Hewlett; James S Sutcliffe; Randy D Blakely
Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(32):11545-50.
2005: Chong-Bin Zhu; Ana Carneiro; Wolfgang R Dostmann; William A Hewlett; Randy D Blakely
p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process.
The Journal of biological chemistry 2005;280(16):15649-58.
2004: Chong-Bin Zhu; William A Hewlett; Sharron H Francis; Jackie D Corbin; Randy D Blakely
Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil.
European journal of pharmacology 2004;504(1-2):1-6.
2004: Chong-Bin Zhu; William A Hewlett; Igor Feoktistov; Italo Biaggioni; Randy D Blakely
Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.
Molecular pharmacology 2004;65(6):1462-74.
2003: William A Hewlett; Sabine Schmid; Ronald M Salomon
Pilot trial of ondansetron in the treatment of 8 patients with obsessive-compulsive disorder.
The Journal of clinical psychiatry 2003;64(9):1025-30.
2002: Zhang-Jin Zhang; Bakula L Trivedi; Tomas de Paulis; Dennis E Schmidt; William A Hewlett
Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
Naunyn-Schmiedeberg's archives of pharmacology 2002;365(2):123-32.
2001: Zhang-Jin Zhang; Dennis E Schmidt; Tomas de Paulis; Bakula L Trivedi; Emmanuel S Onaivi; Michael H Ebert; William A Hewlett
Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze.
Pharmacology, biochemistry, and behavior 2001;69(3-4):571-8.
1999: William A Hewlett; Bakula L Trivedi; Zhang-Jin Zhang; Tomas de Paulis; Dennis E Schmidt; David M Lovinger; Mohammad Sib Ansari; Michael H Ebert
Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
The Journal of pharmacology and experimental therapeutics 1999;288(1):221-31.
1998: William A Hewlett; S Fridman; Bakula L Trivedi; Dennis E Schmidt; Tomas de Paulis; Michael H Ebert
Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain.
Progress in neuro-psychopharmacology & biological psychiatry 1998;22(2):397-410.
1998: William A Hewlett; Dennis E Schmidt; N S Mason; Bakula L Trivedi; Michael H Ebert; Tomas de Paulis
Synthesis and 5-HT-3 receptor binding of 2- and 3-(halo)alkoxyl substituted (S)-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chlorobenzamides as potential radioligands.
Nuclear medicine and biology 1998;25(2):141-53.
1997: William A Hewlett; Tomas de Paulis; N S Mason; Dennis E Schmidt; Bakula L Trivedi; Zhang-Jin Zhang; Michael H Ebert
Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinity.
Chemical & pharmaceutical bulletin 1997;45(12):2079-84.
1994: M Wright; William A Hewlett
Neurobiology of obsessive compulsive disorder.
Comprehensive therapy 1994;20(2):95-100.
1992: William A Hewlett; S Vinogradov; W Stewart Agras
Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
Journal of clinical psychopharmacology 1992;12(6):420-30.
1992: William A Hewlett; S Vinogradov; K Martin; S Berman; John G Csernansky
Fenfluramine stimulation of prolactin in obsessive-compulsive disorder.
Psychiatry research 1992;42(1):81-92.
1990: William A Hewlett; S Vinogradov; W Stewart Agras
Clonazepam treatment of obsessions and compulsions.
The Journal of clinical psychiatry 1990;51(4):158-61.